134 related articles for article (PubMed ID: 29019509)
1. Hydroxylation of anilides by engineered cytochrome P450
O'Hanlon JA; Ren X; Morris M; Wong LL; Robertson J
Org Biomol Chem; 2017 Oct; 15(41):8780-8787. PubMed ID: 29019509
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial alanine substitution enables rapid optimization of cytochrome P450BM3 for selective hydroxylation of large substrates.
Lewis JC; Mantovani SM; Fu Y; Snow CD; Komor RS; Wong CH; Arnold FH
Chembiochem; 2010 Dec; 11(18):2502-5. PubMed ID: 21108271
[TBL] [Abstract][Full Text] [Related]
3. Use of perfluorocarboxylic acids to trick cytochrome P450BM3 into initiating the hydroxylation of gaseous alkanes.
Kawakami N; Shoji O; Watanabe Y
Angew Chem Int Ed Engl; 2011 May; 50(23):5315-8. PubMed ID: 21506212
[No Abstract] [Full Text] [Related]
4. P450
Beyer N; Kulig JK; Bartsch A; Hayes MA; Janssen DB; Fraaije MW
Appl Microbiol Biotechnol; 2017 Mar; 101(6):2319-2331. PubMed ID: 27900443
[TBL] [Abstract][Full Text] [Related]
5. Biocatalytic route to chiral acyloins: P450-catalyzed regio- and enantioselective α-hydroxylation of ketones.
Agudo R; Roiban GD; Lonsdale R; Ilie A; Reetz MT
J Org Chem; 2015 Jan; 80(2):950-6. PubMed ID: 25495724
[TBL] [Abstract][Full Text] [Related]
6. Laboratory-Scale Hydroxylation of Steroids by P450
Hoebenreich S; Spinck M; Nett N
Methods Mol Biol; 2017; 1645():239-257. PubMed ID: 28710633
[TBL] [Abstract][Full Text] [Related]
7. Molecular Determinants of Substrate Affinity and Enzyme Activity of a Cytochrome P450
Geronimo I; Denning CA; Heidary DK; Glazer EC; Payne CM
Biophys J; 2018 Oct; 115(7):1251-1263. PubMed ID: 30224054
[TBL] [Abstract][Full Text] [Related]
8. Designer Outer Membrane Protein Facilitates Uptake of Decoy Molecules into a Cytochrome P450BM3-Based Whole-Cell Biocatalyst.
Karasawa M; Yonemura K; Stanfield JK; Suzuki K; Shoji O
Angew Chem Int Ed Engl; 2022 Feb; 61(7):e202111612. PubMed ID: 34704327
[TBL] [Abstract][Full Text] [Related]
9. Hoodwinking Cytochrome P450BM3 into Hydroxylating Non-Native Substrates by Exploiting Its Substrate Misrecognition.
Shoji O; Aiba Y; Watanabe Y
Acc Chem Res; 2019 Apr; 52(4):925-934. PubMed ID: 30888147
[TBL] [Abstract][Full Text] [Related]
10. Expanding the applicability of cytochrome P450s and other haemoproteins.
Ariyasu S; Stanfield JK; Aiba Y; Shoji O
Curr Opin Chem Biol; 2020 Dec; 59():155-163. PubMed ID: 32781431
[TBL] [Abstract][Full Text] [Related]
11. Effect of Mutation and Substrate Binding on the Stability of Cytochrome P450BM3 Variants.
Geronimo I; Denning CA; Rogers WE; Othman T; Huxford T; Heidary DK; Glazer EC; Payne CM
Biochemistry; 2016 Jun; 55(25):3594-606. PubMed ID: 27267136
[TBL] [Abstract][Full Text] [Related]
12. High-specificity synthesis of novel monomers by remodeled alcohol hydroxylase.
Zheng Y; Li L; Liu Q; Zhang H; Cao Y; Xian M; Liu H
BMC Biotechnol; 2016 Aug; 16(1):61. PubMed ID: 27557638
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450 catalyzed oxidative hydroxylation of achiral organic compounds with simultaneous creation of two chirality centers in a single C-H activation step.
Roiban GD; Agudo R; Reetz MT
Angew Chem Int Ed Engl; 2014 Aug; 53(33):8659-63. PubMed ID: 24590553
[TBL] [Abstract][Full Text] [Related]
14. Free energy calculations give insight into the stereoselective hydroxylation of α-ionones by engineered cytochrome P450 BM3 mutants.
de Beer SB; Venkataraman H; Geerke DP; Oostenbrink C; Vermeulen NP
J Chem Inf Model; 2012 Aug; 52(8):2139-48. PubMed ID: 22765880
[TBL] [Abstract][Full Text] [Related]
15. A highly active single-mutation variant of P450BM3 (CYP102A1).
Whitehouse CJ; Bell SG; Yang W; Yorke JA; Blanford CF; Strong AJ; Morse EJ; Bartlam M; Rao Z; Wong LL
Chembiochem; 2009 Jul; 10(10):1654-6. PubMed ID: 19492389
[TBL] [Abstract][Full Text] [Related]
16. An Evolved Orthogonal Enzyme/Cofactor Pair.
Reynolds EW; McHenry MW; Cannac F; Gober JG; Snow CD; Brustad EM
J Am Chem Soc; 2016 Sep; 138(38):12451-8. PubMed ID: 27575374
[TBL] [Abstract][Full Text] [Related]
17. Functional interactions in cytochrome P450BM3: flavin semiquinone intermediates, role of NADP(H), and mechanism of electron transfer by the flavoprotein domain.
Murataliev MB; Klein M; Fulco A; Feyereisen R
Biochemistry; 1997 Jul; 36(27):8401-12. PubMed ID: 9204888
[TBL] [Abstract][Full Text] [Related]
18. The role of protein plasticity in computational rationalization studies on regioselectivity in testosterone hydroxylation by cytochrome P450 BM3 mutants.
de Beer SB; van Bergen LA; Keijzer K; Rea V; Venkataraman H; Guerra CF; Bickelhaupt FM; Vermeulen NP; Commandeur JN; Geerke DP
Curr Drug Metab; 2012 Feb; 13(2):155-66. PubMed ID: 22208530
[TBL] [Abstract][Full Text] [Related]
19. Hydroxylation of non-substituted polycyclic aromatic hydrocarbons by cytochrome P450 BM3 engineered by directed evolution.
Sideri A; Goyal A; Di Nardo G; Tsotsou GE; Gilardi G
J Inorg Biochem; 2013 Mar; 120():1-7. PubMed ID: 23262457
[TBL] [Abstract][Full Text] [Related]
20. Molecular Dynamics and QM/MM Calculations Predict the Substrate-Induced Gating of Cytochrome P450 BM3 and the Regio- and Stereoselectivity of Fatty Acid Hydroxylation.
Dubey KD; Wang B; Shaik S
J Am Chem Soc; 2016 Jan; 138(3):837-45. PubMed ID: 26716578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]